Page last updated: 2024-09-03

alanylglutamine and Neoplasms

alanylglutamine has been researched along with Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boelens, PG; De Bandt, JP; Dejong, CH; Deutz, NE; Ligthart-Melis, GC; van de Poll, MC; van den Tol, MP; van Leeuwen, PA; van Schaik, C; Vermeulen, MA	1
Benes, P; Chocenská, E; Gregora, E; Kozák, T; Patorková, M; Procházka, B; Pytlík, R	1
Ollenschläger, G; Roth, E; Simmel, A	1

Trials

1 trial(s) available for alanylglutamine and Neoplasms

Article	Year
Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study. Bone marrow transplantation, 2002, Volume: 30, Issue:12 Topics: Adult; Analgesics, Opioid; Anti-Bacterial Agents; Body Composition; C-Reactive Protein; Cholinesterases; Cost-Benefit Analysis; Diarrhea; Dietary Supplements; Dipeptides; Disease-Free Survival; Double-Blind Method; Female; Humans; Intestine, Small; Length of Stay; Male; Middle Aged; Neoplasms; Parenteral Nutrition; Peripheral Blood Stem Cell Transplantation; Serum Albumin; Solutions; Stomatitis; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Failure; Treatment Outcome	2002

Article

Year

Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study.

Bone marrow transplantation, 2002, Volume: 30, Issue:12

Topics: Adult; Analgesics, Opioid; Anti-Bacterial Agents; Body Composition; C-Reactive Protein; Cholinesterases; Cost-Benefit Analysis; Diarrhea; Dietary Supplements; Dipeptides; Disease-Free Survival; Double-Blind Method; Female; Humans; Intestine, Small; Length of Stay; Male; Middle Aged; Neoplasms; Parenteral Nutrition; Peripheral Blood Stem Cell Transplantation; Serum Albumin; Solutions; Stomatitis; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Failure; Treatment Outcome

2002

Other Studies

2 other study(ies) available for alanylglutamine and Neoplasms

Article	Year
Enteral administration of alanyl-[2-(15)N]glutamine contributes more to the de novo synthesis of arginine than does intravenous infusion of the dipeptide in humans. The American journal of clinical nutrition, 2009, Volume: 90, Issue:1 Topics: Arginine; Body Mass Index; Citrulline; Dipeptides; Enteral Nutrition; Female; Gastrointestinal Diseases; Glutamine; Humans; Infusions, Intravenous; Isotope Labeling; Male; Middle Aged; Neoplasms; Nitrogen Isotopes	2009
Availability of glutamine from peptides and acetylglutamine for human tumor-cell cultures. Metabolism: clinical and experimental, 1989, Volume: 38, Issue:8 Suppl 1 Topics: Breast Neoplasms; Cell Division; Dipeptides; DNA; Glutamine; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms; Tumor Cells, Cultured	1989

Article

Year

Enteral administration of alanyl-[2-(15)N]glutamine contributes more to the de novo synthesis of arginine than does intravenous infusion of the dipeptide in humans.

The American journal of clinical nutrition, 2009, Volume: 90, Issue:1

Topics: Arginine; Body Mass Index; Citrulline; Dipeptides; Enteral Nutrition; Female; Gastrointestinal Diseases; Glutamine; Humans; Infusions, Intravenous; Isotope Labeling; Male; Middle Aged; Neoplasms; Nitrogen Isotopes

2009

Availability of glutamine from peptides and acetylglutamine for human tumor-cell cultures.

Metabolism: clinical and experimental, 1989, Volume: 38, Issue:8 Suppl 1

Topics: Breast Neoplasms; Cell Division; Dipeptides; DNA; Glutamine; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms; Tumor Cells, Cultured

1989